Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis. 1984

R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa

The clinical significance of serum alpha-fetoprotein (AFP) was studied in 114 patients with liver cirrhosis, who were followed for more than one year. Out of 114 patients, serum HBs antigen (HBsAg) was positive in 49 (43%). The mean follow-up period was 4.3 years (from 1 to 13 years). Serial determinations of AFP by RIA were performed once a month in all patients. The pattern of serial changes of AFP levels could be divided into three characteristic types: 1) fluctuation of AFP levels to greater than 20ng/ml was observed in 39 cases (Type I); 2) a transient rise of AFP levels to greater than 50ng/ml was observed in 20 cases (Type II); 3) in the remaining 55 cases, AFP levels were always less than 20ng/ml. During the follow-up period, liver cell carcinoma (LCC) developed in 29 cases (25%) and hepatic failure in 11 cases (10%). The incidence of LCC was significantly higher in Type I (18/39, 46%) than in Type II (3/20, 15%) and Type III (8/55, 15%). It is concluded that cirrhotic patients with fluctuation of AFP levels should be included in the high-risk group for LCC.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
January 1979, Medicinski pregled,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
March 1993, Revista clinica espanola,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
August 1975, Annals of the New York Academy of Sciences,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
June 1974, British medical journal,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
November 1989, Harefuah,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
January 1997, Roczniki Akademii Medycznej w Bialymstoku (1995),
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
January 1976, Zeitschrift fur Gastroenterologie. Verhandlungsband,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
January 1977, Digestion,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
July 1983, American journal of obstetrics and gynecology,
R Furukawa, and H Tajima, and K Nakata, and K Kono, and T Muro, and A Sato, and K Kawahara, and N Ishii, and Y Kusumoto, and T Munehisa
January 1986, Medicinski arhiv,
Copied contents to your clipboard!